Cargando…
Radiotherapy-induced enrichment of EGF-modified doxorubicin nanoparticles enhances the therapeutic outcome of lung cancer
Chemotherapy is the primary treatment for advanced non-small-cell lung cancer (NSCLC). However, related dose-dependent toxicity limits its clinical use. Therefore, it is necessary to explore new strategies for improving the clinical outcomes while reducing the side effects of chemotherapy in the tre...
Autores principales: | Wang, Jing, Zhang, Yan, Zhang, GuangPeng, Xiang, Li, Pang, HaoWen, Xiong, Kang, Lu, Yun, Li, JianMei, Dai, Jie, Lin, Sheng, Fu, ShaoZhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856057/ https://www.ncbi.nlm.nih.gov/pubmed/35156493 http://dx.doi.org/10.1080/10717544.2022.2036871 |
Ejemplares similares
-
Therapeutic effects of EGF-modified curcumin/chitosan nano-spray on wound healing
por: Li, Yue, et al.
Publicado: (2021) -
Albumin-Modified Gold Nanoparticles as Novel Radiosensitizers for Enhancing Lung Cancer Radiotherapy
por: Chen, Yao, et al.
Publicado: (2023) -
Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy
por: Chen, Yao, et al.
Publicado: (2020) -
Hyaluronic Acid-Modified and Doxorubicin-Loaded Gold Nanoparticles and Evaluation of Their Bioactivity
por: Li, Lin-Song, et al.
Publicado: (2021) -
Preparation of Cationic Amphiphilic Nanoparticles with Modified Chitosan Derivatives for Doxorubicin Delivery
por: Liu, Xiudong, et al.
Publicado: (2021)